Emergent BioSolutions Names Robert G. Kramer CFO

Emergent BioSolutions

today announced that Robert G. Kramer has been appointed as the company's chief financial officer effective December 3, 2012. Mr. Kramer succeeds R. Don Elsey, who will be leaving to pursue a new opportunity at a private healthcare company. Mr. Kramer is currently executive vice president, corporate services division, and with this appointment, his title will become executive vice president, corporate services division and chief financial officer, reporting directly to Daniel J. Abdun-Nabi, Emergent's president and chief executive officer. “Bob has been a major part of Emergent's success through the years and has been intimately involved in the development of our recently announced growth plan. Together, we look forward to achieving